Catalyst
Slingshot members are tracking this event:
Zimmer Biomet (ZBH) Announces Interim Results from Pivotal MOBILE Study of its Autologous Concentrated Bone Marrow Aspirate (cBMA) Prepared with the MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ZBH |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 15, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Interim Results, Mobile, Pivotal Study, Autologous Concentrated Bone Marrow Aspirate, Cbma, Marrowstim Pad Kit, Critical Limb Ischemia
